“…As a consequence, retrotransposition is ongoing in the current human population, and new heritable LINE-1 insertions can sporadically cause genetic disease (Hancks and Kazazian, 2016;Kazazian et al, 1988). are also active in some somatic tissues, such as the brain (Baillie et al, 2011;Coufal et al, 2011;Evrony et al, 2012;Macia et al, 2017;Muotri et al, 2005;Upton et al, 2015) or epithelial tumors (Doucet-O'Hare et al, 2016;Ewing et al, 2015;Helman et al, 2014;Iskow et al, 2010;Lee et al, 2012;Miki et al, 1992;Rodic et al, 2015;Schauer et al, 2018;Scott et al, 2016;Shukla et al, 2013;Solyom et al, 2012;Tang et al, 2017;Tubio et al, 2014), recently reviewed in (Carreira et al, 2013;Scott and Devine, 2017)). In contrast, retrotransposition in other somatic tissues may be uncommon (Garcia-Perez et al, 2016;Macia et al, 2017).…”